Adu Subramanian
@plainyogurt21
Future MD, Bioengineer, Investor, Member at http://Microcapclub.com, Call Leader @Slingshot_Invst, http://www.subradata.com, http://adus.substack.com
You might like
As we approach Q4, here's the catalyst Tracker for any company with active SEC filings. LMK if a company is missing and I can add it. subradata.com/catalyst_data_…
Last couple weeks have been electric. May the thunder roll into Q4 $XBI $BBC Some upcoming catalysts that are on my radar: $JANX PSMA / EGFR Ph1 $AGIO PKR SCD Ph3 $FULC SCD Ph1b $RZLT cHI Ph3 $GOSS PAH Ph3 $ZBIO IgG4-RD Ph3 $IMVT TED Ph3 $PVLA cVM Ph2 $BBIO ADH1 Ph3 / LGMD2i…
I have a few accounts with notifications on when they tweet. @Biotenic is one of them High signal:noise ratio Nuff said
One more most important thing over the past few years @biotenic ‘s research and overall grasp on the science , has helped me multifold. If anyone in the industry is hiring , or knows anyone hiring please reach out. Honestly can’t recommend him enough. He only graduated last…
$AMGN $INCY? $TEVA. Evaluation of AMG 714 for Vitiligo clinicaltrials.gov/study/NCT04338…. fail primary 15% F-Vasi 35 vs PBO 5%. (we knew this was d/c already) $FBRX in Q1 with CD122. Better molecule and preserves Tregs. Can it work
pubmed.ncbi.nlm.nih.gov/41002258/ $NKTR "Four refractory AA patients (median follow-up: 32.5 months) with complete hair regrowth (SALT = 0) after ≥6 months of tofacitinib received adjunctive IL-2. Three patients maintained complete remission for 11-20 months after treatment cessation,…
Are we skipping over the fact that the trial also enrolled patients with SALT100? those patients were absolutely cooked. That paper does not provide a negative readthrough to NKTR. This is the PoC trial. I lean positive because of the anecdata from the prior case series in 5…
Who is out there doing the latter? I think it’s the biotech of the future: ideas to execution. It’s about finding and DESIGNING the right trial. Trial success is 25% the drug and 75% the design/execution/right market of the trial to show it. (See $OCUL going for superiority in…
Recent advancements in one-shot AI protein / antibody development by Chai, Nabla, AI Proteins, Generate, and a few others are accelerating the *main* theme in biotech: Value of building the molecule is going down. The value of novel targets, novel translational ideas, AND also…
$TECX I will repeat myself over and over again: TECX is running a PH trial, not a HFpEF trial. Two different diseases. The pathology is shifting to the Right heart, not the left heart
$MRK inclusion is >4WU PVR. Different population than $TECX > 2 PVR. 70% greater than 3PVR.
$MRK inclusion is >4WU PVR. Different population than $TECX > 2 PVR. 70% greater than 3PVR.
PH-HFpEF space heating up 🔥 - $tecx relaxin mimetic ph2 2026 - $tenx levosimendan (inodilator) ph3 2026 - $azn relaxin mimetic ph2 readout 2025 (still waiting) - $mrk activin inhibitor ph2 positive (announced today) / already approved in PAH (group 1 PH), to initiate phase 3…
I think THe FDA stuff is BS. Can't flip flop with this, but on $QURE, I disagree on the NfL validity in this population. We're introducing invasive brain surgery which increases the NfL initially before reducing it at 3 years. We don't know how this NfL changes the dynamics of…
First of all, props to the author of this first time biotech write up on $QURE. It takes a lot of time and courage to put your stuff out there, but it is an unrivaled way to learn. Now, there are several things I disagree with in the article, so I'll do my part and perhaps…
Here's the PK data I could find out there.
Should everyone be microdosing a GLP1 (once generic/affordable)? IMO willpower required to stay at stable weight would be better spent elsewhere. Plus anti inflammatory effects....
$AGIO functional unblinding may be an interesting factor. It's essentially a blood vitamin for people who lack blood health. Combine that with hemoglobin increases (don't happen on placebo) and patients on drug may know it.....
Turns out 2+2 did indeed equal 4, or put another way….HR .5 $COGT
Hot take: a lot of stuff we do in medicine isn't supported by "perfect" evidence. Sometimes (most of the time), medicine is leaning into the vibes. Hard to believe anyone will run this trial well. And if safe/affordable, what is the downside of microdosing a GLP?
There is no peer-reviewed scientific evidence that shows microdosing GLP-1RA drugs is effective or safe. @theaace does not support the routine use of microdosing GLP-1RA medications in clinical care and recommends adherence to FDA-approved dosing guidelines for these agents.…
$TECX still no news from $AZN results supposedly 2h25 for re phire Azd 3427
United States Trends
- 1. #socideveloper_com N/A
- 2. #lip_bomb_RESCENE N/A
- 3. #River 3,949 posts
- 4. #heatedrivalry 17.9K posts
- 5. Ravens 59.2K posts
- 6. ilya 18.4K posts
- 7. Lamar 46.9K posts
- 8. Shane 22K posts
- 9. #DaesangForJin 19K posts
- 10. Bengals 52.8K posts
- 11. Black Friday 271K posts
- 12. Joe Burrow 21.4K posts
- 13. Connor 15.5K posts
- 14. BNB Chain 8,396 posts
- 15. Zay Flowers 4,249 posts
- 16. hudson 12.2K posts
- 17. Sarah Beckstrom 229K posts
- 18. Third World Countries 30K posts
- 19. scott hunter N/A
- 20. Derrick Henry 4,495 posts
You might like
-
Laughing Water Capital
@LaughingH20Cap -
Adam Wilk
@AKWilk -
Michael Liu
@michael2017l -
Maxwell House
@maxwellhouse99 -
Avram Fisher
@longcastadviser -
Andy 🍕🏔️
@bizalmanac -
Luke Wolgram🔥
@LukeWolgram -
Smoak Capital
@dsmoak98 -
Hidden Small Caps (Mike)
@hiddensmallcaps -
Tim Eriksen
@eriksen_tim -
BioCompounding
@BioCompounding -
BullishDoctor
@NeuroStockDoc -
Jason Hirschman
@EightTrack180 -
MicroValue
@ValueStalker -
MBB
@LockStockBarrl
Something went wrong.
Something went wrong.